Shanghai Ruijin Hospital
Deputy Chief Physician, M.D.
He is a member of Member of MDT committee of Precision Medicine and Oncology, Chinese Research Hospital Association, Clinical Epidemiology and Evidence-based Medicine Branch of Shanghai Medical Association, Anti-tumor Group of Clinical Pharmacy Branch of Shanghai Medical Association, Tumor Precision Treatment Committee of the Shanghai Anti-Tumor Association.
- Deputy Chief Physician of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Member of Tumor Palliative Care Committee Youth committee of Chinese Medical Association
- Member of Early Diagnosis and Treatment Group, Oncology Branch, Chinese Medical Association
- Dr. Li has long been engaged in the research of targeted therapy, immunotherapy and the molecular mechanism of the development of gastric cancer. From 2007 to 2008, he was a visiting scholar at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, United States, working on anti-immune checkpoint therapy. He has led or participated in 4 national and municipal scientific research projects, published more than 10 papers, and participated in the compilation of 4 works.